Novonesis (Novozymes) B/ DK0060336014 /
2024-11-07 3:23:49 PM | Chg. -5.50 | Volume | Bid2024-09-25 | Ask2024-11-06 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
421.90DKK | -1.29% | 807 Turnover: 337,434.90 |
-Bid Size: - | -Ask Size: - | 116.33 bill.DKK | 1.00% | 38.42 |
Assets
2011 IFRS in mill. DKK |
2012 IFRS in mill. DKK |
2013 IFRS in mill. DKK |
2014 IFRS in mill. DKK |
2015 IFRS in mill. DKK |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 6,557 | 7,084 | 7,135 | 7,498 | 8,162 | ||||||
Intangible Assets | 2,221 | 2,672 | 2,864 | 2,954 | 2,676 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 14 | 29 | 139 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 1,741 | 1,808 | 1,902 | 2,184 | 2,281 | ||||||
Accounts Receivable | 1,971 | 2,080 | 2,242 | 2,244 | 2,558 | ||||||
Cash and Cash Equivalents | 667 | 535 | 1,003 | 2,535 | 839 | ||||||
Current Assets | 4,789 | 4,890 | 5,686 | 7,311 | 6,148 | ||||||
Total Assets | 13,842 | 15,113 | 16,506 | 18,426 | 17,791 |
Liabilities
2011 IFRS in mill. DKK |
2012 IFRS in mill. DKK |
2013 IFRS in mill. DKK |
2014 IFRS in mill. DKK |
2015 IFRS in mill. DKK |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 745 | 1,044 | 976 | 1,122 | 1,189 | ||||||
Long-term debt | 1,604 | 1,749 | 1,734 | 1,242 | 1,216 | ||||||
Liabilities to Banks | 1,862 | 2,035 | 1,839 | 1,972 | 1,332 | ||||||
Provisions | 1,192 | 1,342 | 1,591 | 1,452 | 1,325 | ||||||
Liabilities | 5,018 | 5,545 | 5,440 | 7,146 | 6,198 | ||||||
Share Capital | 650 | 650 | 639 | 639 | 626 | ||||||
Total Equity | 8,809 | 9,555 | 11,054 | 11,269 | 11,580 | ||||||
Minority Interests | 15 | 13 | 12 | 11 | 13 | ||||||
Total liabilities equity | 13,842 | 15,113 | 16,506 | 18,426 | 17,791 |
Income Statement
2011 IFRS in mill. DKK |
2012 IFRS in mill. DKK |
2013 IFRS in mill. DKK |
2014 IFRS in mill. DKK |
2015 IFRS in mill. DKK |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 10,510 | 11,234 | 11,746 | 12,459 | 14,002 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 2,340 | 2,745 | 2,901 | 3,384 | 3,884 | ||||||
Interest Income | 75 | -161 | -142 | -105 | -257 | ||||||
Income Before Taxes | 2,415 | 2,584 | 2,759 | 3,279 | 3,621 | ||||||
Income Taxes | 587 | 568 | 558 | 754 | 796 | ||||||
Minority Interests Profit | -2 | -1 | -1 | 1 | -2 | ||||||
Net Income | 1,826 | 2,015 | 2,200 | 2,526 | 2,823 |
Per Share
Cash Flow
2011 IFRS in mill. DKK |
2012 IFRS in mill. DKK |
2013 IFRS in mill. DKK |
2014 IFRS in mill. DKK |
2015 IFRS in mill. DKK |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 2,709 | 2,758 | 2,599 | 4,525 | 3,339 | ||||||
Cash Flow from Investing Activities | -2,742 | -1,909 | -1,423 | -310 | -1,257 | ||||||
Cash Flow from Financing | -656 | -1,165 | -532 | -2,703 | -3,681 | ||||||
Decrease / Increase in Cash | -700 | -294 | 612 | 1,511 | -1,657 | ||||||
Employees | 5,824 | 6,041 | 6,236 | 6,454 | 6,485 |